International Diabetes Federation appoints Dr RM Anjana as Chair of IDF Working Group

IMT News Desk
IMT News Desk
· 2 min read

Dr Anjana will form and guide an international consortium with representatives from all IDF regions, ensuring global collaboration, regional balance and gender diversity

The International Diabetes Federation (IDF) announced the appointment of Dr RM Anjana, MD, Dr Mohan’s Diabetes Specialities Centre and President of the Madras Diabetes Research Foundation (MDRF), as the Chair of the IDF Working Group on Physical Activity and to lead the IDF Global ‘ACTIVE’ Initiative. This pioneering initiative aims at increasing physical activity across the globe.

In this prominent leadership role, Dr Anjana will form and guide an international consortium with representatives from all IDF regions, ensuring global collaboration, regional balance and gender diversity.

Prof Peter Schwarz – President, International Diabetes Federation said, “Increasing physical activity is one of the most effective interventions we have to prevent diabetes and enhance global health. The IDF Physical Activity Working group and ACTIVE Initiative is an important step toward addressing inactivity worldwide. Under Dr Anjana’s leadership, this group and its initiatives will translate global evidence into practical, community-driven action. IDF is proud to support this global movement and looks forward to the transformation it will bring.”

Dr Anjana said, “I am deeply honoured to Chair the IDF working group on Physical Activity and lead the IDF ‘ACTIVE’ Initiative. Physical inactivity has become a global crisis and we need bold, actionable strategies, not just discussions. This initiative is designed to inspire children, adults and the elderly to embrace active living through structured, sustainable programs. By bringing together experts from every IDF region, we hope to drive a worldwide movement that will meaningfully reduce the burden of diabetes and other chronic diseases.”

Dr V Mohan, Chairman, Dr Mohan’s Diabetes Specialities Centre & Madras Diabetes Research Foundation added, “This is a moment of great pride for our organisation and for India. Dr Anjana’s contributions to physical activity research and her leadership in community health make her the ideal choice to spearhead this global initiative. The IDF ACTIVE Initiative is poised to become a landmark program that will create real impact across continents.”

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk